Skip to main content
Funded Studies

Anthony B. Pinkerton, PhD

Vice President, Medicinal Chemistry at Sanford Burnham Prebys Medical Discovery Institute

Location: La Jolla, CA United States

Dr. Anthony B. Pinkerton trained as a synthetic organic chemist in the laboratories of Dieter Seebach (ETH-Zurich) and Barry Trost (Stanford University). His industry career began at Merck Research Laboratories (San Diego). Over his career Dr. Pinkerton has worked in multiple areas including CNS, virology, diabetes, inflammation, and oncology, with extensive experience in G protein-coupled receptors. He has been both project leader and project manager, as well as chemistry lead for the metabolic disease team, where he helped identify and prosecute the most promising new targets in the field. He has performed due diligence for in-licensing efforts and competitive intelligence for multiple targets, in addition to developing IP strategies around multiple chemical series. In addition to numerous publications, Dr. Pinkerton is inventor/co-inventor on 40+ patents or patent applications covering small-molecule therapeutics. He has helped advance five compounds into clinical development.

Associated Grants

  • Managing Levodopa-induced Dyskinesias by Targeting Dopamine D1 Receptor Signaling


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.